In vitro binding of an orally active platinum antitumor drug, JM216 to metallothionein

By Xing B.  

BioMetals, Vol. 14, Iss. 1, 2001-03 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

Borato-1,2-diaminocyclohexane Platinum (II), a Novel Anti-Tumor Drug

By Dibas A.   Howard J.   Anwar S.   Stewart D.   Khan A.  

Biochemical and Biophysical Research Communications, Vol. 270, Iss. 2, 2000-04 ,pp. : 383-386

Elsevier

Access to resources Recommend Favorite

Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin

By Kasparkova Jana   Fojta Miroslav   Farrell Nicholas  

Nucleic Acids Research, Vol. 32, Iss. 18, 2004-01 ,pp. : 5546-5552

Oxford University Press

Access to resources Recommend Favorite

A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity

By Welinder Charlotte   Baldetorp Bo   Borrebaeck Carl   Fredlund Britt-Marie   Jansson Bo  

Glycobiology, Vol. 21, Iss. 8, 2011-08 ,pp. : 1097-1107

Oxford University Press

Access to resources Recommend Favorite

Proteolytic Fragments of Anti-HIV and Anti-tumor Proteins MAP30 and GAP31 Are Biologically Active

By Huang P.L.   Sun Y.   Chen H-C.   Kung H-F.   Huang P.L.   Lee-Huang S.  

Biochemical and Biophysical Research Communications, Vol. 262, Iss. 3, 1999-09 ,pp. : 615-623

Elsevier

Access to resources Recommend Favorite